相关实验视频
Updated: Jun 3, 2025

07:49
Measuring Local Anaphylaxis in Mice
Published on: October 14, 2014
19.3K
多活性个体中的 Culprit 过敏原患病率反映了处方趋势:使用神经肌肉阻断剂的例子来估计比较过敏症风险的工具
Paul Hm Sadleir1,2, Catherine E Goddard1,2, Russell C Clarke1,2
1Department of Anaesthesia, Sir Charles Gairdner Hospital, Nedlands, Australia.
Anaesthesia and intensive care
|January 6, 2025
概括
一种新方法使用交叉反应数据估计罕见药物副作用风险,绕过传统方法. 这种方法发现罗库的过敏反应风险比韦库高2.2倍,与之前的发现保持一致.
科学领域:
- 药物监督 药物监督 药物监督
- 免疫学 免疫学 免疫学
- 临床毒理学 临床毒理学
背景情况:
- 处方事件监测 (PEM) 是罕见药物副作用风险评估的标准,但在病例检测和暴露估计方面存在局限性.
- 自发报告计划也遭受了低检测率和难以估计药物暴露的困难.
- 提出了一种新方法,用交叉反应模式来估计比较的不良事件率,只需要没有直接暴露数据的病例样本.
研究的目的:
- 开发和验证一种基于交叉反应性的新方法来估计基于交叉反应的药物不良反应比较率.
- 为了将新方法的估计值与罗库的历史处方事件监测 (PEM) 数据与韦库的过敏反应风险进行比较.
- 评估交叉活性数据在估计相对药物暴露和不良事件风险方面的有用性.
主要方法:
- 将一种基于交叉反应的新方法应用于西澳大利亚麻醉药物反应诊所的21岁患者样本.
- 估计的相对人群暴露通过分析皮肤测试对罗库和维库的反应性在过敏反应病例.
- 对估计的暴露率进行了校正,并将结果与基于文献的PEM和历史估计进行了比较.
主要成果:
- 在228例观察到的过敏反应病例中,罗库与89%的病例有关.
- 对这两种药物有反应的患者更有可能是女性,并且患有更高的急性巨细胞三酶水平.
- 这种新方法估计罗库的过敏反应风险是维库的2.2倍 (95%CI1.72.8),与PEM估计一致.
结论:
- 使用交叉活性数据的新方法可以有效地估计相对药物不良反应风险和相对暴露率.
- 这种技术为传统的药监方法提供了有价值的替代方案,特别是在罕见事件中.
- 该研究证实,与西澳大利亚的Vecuronium相比,Rocuronium具有显著更高的过敏反应风险.
相关概念视频
Allergic Reactions
27.2K
Overview
27.2K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
390
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
390
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
236
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
236
Allergic Drug Reactions
809
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
809
Adrenergic Agonists: Therapeutic Uses
725
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
725
Drugs Used in Lower Respiratory Disorders: Overview
349
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
349

